Publication
Words of wisdom. Re: Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer
Journal Paper/Review - Oct 1, 2009
Schmid Hans-Peter, Engeler Daniel
Units
PubMed
Doi
Citation
Schmid H, Engeler D. Words of wisdom. Re: Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. European urology 2009; 56:744-5.
Type
Journal Paper/Review (English)
Journal
European urology 2009; 56
Publication Date
Oct 1, 2009
Issn Electronic
1873-7560
Pages
744-5